BXRX Research and Charts

BXRX - Baudax Bio Inc Ordinary Shares (Healthcare: Biotechnology)

Projected Earnings Date: 2024-06-09 (Delayed quote data )

Last	Change ⇓ 0.00 (%)	Volume 0
	Open	High	Low

8EMA (Daily) 0.00	40EMA (Daily)	50EMA (Daily)	STO (Daily)	MACD Hist (Daily)
8EMA (Weekly) 0.028	40EMA (Weekly) 5.08	50EMA (Weekly) 16.13	STO (Weekly) 9.833	MACD Hist (Weekly) 1.277


Company Profile
Baudax Bio Inc is a Pharmaceutical company. The company develops and commercialize products for hospital and related acute care settings. Its products are in pipeline which includes two novel neuromuscular blocking agents, or NMBAs, and a related proprietary chemical reversal agent and Dex-IN.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.